These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21673562)

  • 1. Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in Kenya.
    Kohler PK; Chung MH; McGrath CJ; Benki-Nugent SF; Thiga JW; John-Stewart GC
    AIDS; 2011 Aug; 25(13):1657-61. PubMed ID: 21673562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival with co-trimoxazole prophylaxis among people living with HIV/AIDS who initiated antiretroviral treatment in Henan Province, China.
    Zhu Q; Wang L; Lin W; Bulterys M; Yang W; Sun D; Cui Z; Kaplan J; Kleinman N; Wei X; Chung J; Wang Z
    Curr HIV Res; 2014; 12(5):359-65. PubMed ID: 25426939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of cotrimoxazole in people with advanced HIV infection initiating antiretroviral therapy in sub-Saharan Africa.
    Abimbola TO; Marston BJ
    J Acquir Immune Defic Syndr; 2012 May; 60(1):e8-e14. PubMed ID: 22240461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of people on antiretroviral treatment in Zambia: a retrospective cohort analysis of HIV clients on ART.
    Amanzi P; Michelo C; Simoonga C; Dambe R; Chongwe G
    Pan Afr Med J; 2016; 24():144. PubMed ID: 27642482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twelve months antiretroviral therapy retention among clients newly enrolled to care and treatment services in Geita Regin, Tanzania: does universal test and treat matter?
    Masuke R; Kihaga Y; Mashala M; Ndalio S; Sukari O; Panga O
    Pan Afr Med J; 2023; 46():20. PubMed ID: 38035160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving rates of cotrimoxazole prophylaxis in resource-limited settings: implementation of a quality improvement approach.
    Bardfield J; Agins B; Palumbo M; Wei AL; Morris J; Marston B;
    Int J Qual Health Care; 2014 Dec; 26(6):613-22. PubMed ID: 25335758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.
    Eholié SP; Ello FN; Coffie PA; Héma A; Minta DK; Sawadogo A
    Trop Med Int Health; 2017 Sep; 22(9):1186-1195. PubMed ID: 28653454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda.
    Castelnuovo B; Musaazi J; Musomba R; Ratanshi RP; Kiragga AN
    BMC Infect Dis; 2015 Jul; 15():252. PubMed ID: 26126616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities for improving the efficiency of paediatric HIV treatment programmes.
    Revill PA; Walker S; Mabugu T; Nathoo KJ; Mugyenyi P; Kekitinwa A; Munderi P; Bwakura-Dangarembizi M; Musiime V; Bakeera-Kitaka S; Nahirya-Ntege P; Walker AS; Sculpher MJ; Gibb DM
    AIDS; 2015 Jan; 29(2):201-10. PubMed ID: 25396263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi.
    Lowrance D; Makombe S; Harries A; Yu J; Aberle-Grasse J; Eiger O; Shiraishi R; Marston B; Ellerbrock T; Libamba E
    J Acquir Immune Defic Syndr; 2007 Sep; 46(1):56-61. PubMed ID: 17972365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
    Hoffmann CJ; Fielding KL; Charalambous S; Innes C; Chaisson RE; Grant AD; Churchyard GJ
    AIDS; 2010 Jul; 24(11):1709-16. PubMed ID: 20495439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study.
    Hassan AS; Fielding KL; Thuo NM; Nabwera HM; Sanders EJ; Berkley JA
    Trop Med Int Health; 2012 Jan; 17(1):82-93. PubMed ID: 22943164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China.
    Cheng W; Wu Y; Wen Y; Ma Y; Zhao D; Dou Z; Zhang W; Bulterys M; Zhang F
    Bull World Health Organ; 2015 Mar; 93(3):152-60. PubMed ID: 25838611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey.
    Wafula R; Masyuko S; Ng'ang'a L; Kim AA; Gichangi A; Mukui I; Batuka J; Ngugi EW; Maina WK; Schwarcz S;
    J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S98-105. PubMed ID: 24732825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis.
    Ottichilo RK; Polyak CS; Guyah B; Singa B; Nyataya J; Yuhas K; John-Stewart G; Waitumbi JN
    J Infect Dis; 2017 Jan; 215(1):88-94. PubMed ID: 28077587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.
    Goldie SJ; Yazdanpanah Y; Losina E; Weinstein MC; Anglaret X; Walensky RP; Hsu HE; Kimmel A; Holmes C; Kaplan JE; Freedberg KA
    N Engl J Med; 2006 Sep; 355(11):1141-53. PubMed ID: 16971720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of co-trimoxazole prophylaxis used for AIDS patients under anti-retroviral therapy].
    Yang W; Liang Y; Li J; Ma Y; Li N; Sun D; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):689-94. PubMed ID: 25174473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire: a cohort study.
    Harambat J; Fassinou P; Becquet R; Touré P; Rouet F; Dabis F; Msellati P; Blanche S; Timité-Konan M; Salamon R; Leroy V;
    BMC Public Health; 2008 May; 8():169. PubMed ID: 18492259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with loss to clinic among HIV patients not yet known to be eligible for antiretroviral therapy (ART) in Mozambique.
    Pati R; Lahuerta M; Elul B; Okamura M; Alvim MF; Schackman B; Bang H; Fernandes R; Assan A; Lima J; Nash D;
    J Int AIDS Soc; 2013 Jun; 16(1):18490. PubMed ID: 23755857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial.
    Anywaine Z; Levin J; Kasirye R; Lutaakome JK; Abaasa A; Nunn A; Grosskurth H; Munderi P;
    PLoS One; 2018; 13(12):e0206907. PubMed ID: 30596666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.